Business Insider

Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases

ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear ...
Business Insider

Life Biosciences Presents at AAO Highlighting Progress of Nonhuman Primate Studies Evaluating Partial Epigenetic Reprogramming to Restore Visual Function

BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and ...
BioWorld

Partial epigenetic reprogramming to treat ischemic optic neuropathy

A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...
pharmaphorum

Trends & Insights, January 2026: A pharmaphorum industry report

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
EurekAlert!

The cell rejuvenation atlas: identifying master regulators of rejuvenation strategies

BUFFALO, NY- September 16, 2024 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 17 on ...
EurekAlert!

Leo Foundation: Prof. Buganim's lab at Hebrew University-Grant for pioneering research on fibroblast dysfunction and skin rejuvenation

The Leo Foundation has awarded a $600,000 grant to Prof. Yossi Buganim’s lab at The Hebrew University of Jerusalem to support groundbreaking research on fibroblast dysfunction in aging skin. This ...